PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Revenue Growth (3y) (2023 - 2026)

Analysis

PROCEPT BioRobotics (PRCT) Revenue Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 18.10%
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 8.20%
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 9.66%
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 10.83%
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn 4.73%
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 14.51%
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 8.05%
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn 41.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.86%
Mar 31, 2026 50.47%
Dec 31, 2025 47.55%
Sep 30, 2025 59.99%
Jun 30, 2025 68.03%
Mar 31, 2025 69.52%
Dec 31, 2024 88.81%
Sep 30, 2024 88.84%
Jun 30, 2024 84.64%
Mar 31, 2024 83.64%
Dec 31, 2023 138.29%
Sep 30, 2023 155.40%